Dual blockade of LAG3 and TIGIT improves the treatment efficacy of a nanoparticle-mediated immunoradiation in anti-PD1 resistant lung cancer in mice

Pour en savoir plus sur nos technologies, nos collaborations, nos essais cliniques et d’autres sujets, contactez-nous.